Liquid Silicone-Induced Extensive and Debilitating Granulomatosis Responding to Hydroxychloroquine.
Clicks: 364
ID: 53618
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
8.4
/100
28 views
28 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
In the last two decades, there has been a significant rise in body-image improvement among the American consumers. Cosmetic injectable procedures have increased by 40.6% in the past 5 years. There has also been an increase in nonmedical, illegal, and self-appointed personnel, offering cheaper hazardous procedures. Silicone has been in use since 1965. In 1991, FDA issued guidelines prohibiting the marketing of injectable liquid silicone. However, it is biologically inert, is associated with inflammatory response, and leads to serious complications like granulomatosis, migration, acute pneumonitis, pulmonary embolism, and even death. Here, we present a case of silicone-induced granulomatosis with extensive migration which ended in bilateral mastectomy, multiple anterior chest debulking procedures, and finally peg tube placement due to compression of the esophageal lumen by granulomas. The patient was eventually started on immunomodulatory treatment, hydroxychloroquine with good response.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (133 words).
Try re-searching for a better abstract.
| Reference Key |
jilani2019liquidcase
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jilani, Nargis;Shabbir, Javeria;Nemytova, Elena; |
| Journal | case reports in rheumatology |
| Year | 2019 |
| DOI |
10.1155/2019/8173790
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.